Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5528900 | 0.97 | TSHR (0.40) | FDPSTSHRLMNATDP1THRB | |
| Phosphine SCHEMBL4651873 | 0.94 | FDPS (0.39) | FDPSTSHRTHRBALDH1A1SMPD1 | |
| Ammonia Solution, Strong SCHEMBL524093 | 0.93 | FDPS (0.39) | FDPSTSHRLMNATDP1THRB | |
| SCHEMBL27696187 | 0.93 | FDPS (0.39) | FDPSTSHRLMNATDP1THRB | |
| SCHEMBL27810873 | 0.90 | FDPS (0.37) | FDPSTSHRLMNATDP1THRB | |
| Phosphine SCHEMBL6050501 | 0.88 | TSHR (0.47) | FDPSTSHRTHRBALDH1A1SMPD1 | |
| Ammonia Solution, Strong SCHEMBL11836898 | 0.88 | FDPS (0.39) | FDPSTSHRTHRBALDH1A1SMPD1 | |
| Phosphine SCHEMBL6694555 | 0.88 | TSHR (0.47) | FDPSTSHRTHRBALDH1A1SMPD1 | |
| Ammonia Solution, Strong SCHEMBL11827544 | 0.88 | FDPS (0.39) | FDPSTSHRTHRBALDH1A1SMPD1 | |
| SCHEMBL27965072 | 0.88 | TSHR (0.47) | FDPSTSHRTHRBALDH1A1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9000214-B2 | Process for purifying terephthalic acid using ionic liquids | UOP LLC (US) | 2015-04-07 | — | — | US | disclosed |
| US-20130331603-A1 | Process for Purifying Terephthalic Acid Using Ionic Liquids | UOP LLC | 2013-12-12 | — | — | US | disclosed |
| US-20040181099-A1 | Aromatic ethers and process for producing aromatic ethers | NIPPON SHOKUBAI CO., LTD. (JP) | 2004-09-16 | — | — | US | disclosed |
| EP-0139404-B1 | BIOCIDAL WATER TREATMENT | Albright & Wilson Limited (GB) | 1988-02-03 | — | — | EP | disclosed |
| US-4673509-A | ADDING PHOSPHONIUM COMPOUND | ALBRIGHT & WILSON LIMITED (GB) | 1987-06-16 | — | — | US | disclosed |
| EP-0139404-A1 | Biocidal water treatment | Albright & Wilson Limited (GB) | 1985-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181099-A1 | Aromatic ethers and process for producing aromatic ethers | XDH, FTO, CYP4F8 | FDPS 422/4885TSHR 1258/4885LMNA 4621/4885 |
| US-20130331603-A1 | Process for Purifying Terephthalic Acid Using Ionic Liquids | TST, PAH, OGDH | FDPS 3574/4885TSHR 1365/4885LMNA 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.